Corporate costs cannot be extrapolated. If you read the 4C, $2.7m last quarter was non-recurring relating to the Imbio acquisition. In the Dec 2023 quarter, they would have incurred further non-recurring costs for the Imbio DD and agreements etc too.
Ann: Quarterly Activity Report and Appendix 4C for Q3 FY2024, page-25
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
0.005(1.04%) |
Mkt cap ! $199.4M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.5¢ | 47.0¢ | $241.0K | 509.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 48655 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.5¢ | 11115 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |